As filed with the Securities and Exchange Commission on July 10, 2003
Registration No. 333-
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
______________________________
THE HAIN CELESTIAL GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware 22-3240619
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
58 South Service Road
Melville, New York 11747
(631) 730-2200
(Address, including zip code, and telephone
number, including area code, of
registrant's principal executive
offices)
Irwin D. Simon
Chairman of the Board, President and Chief Executive Officer
The Hain Celestial Group, Inc.
58 South Service Road
Melville, New York 11747
(631) 730-2200
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
______________________________
copy to:
Roger Meltzer, Esq.
Cahill Gordon & Reindel LLP
80 Pine Street
New York, New York 10005
(212) 701-3000
______________________________
Approximate date of commencement of proposed sale to the public: From time
to time after this registration statement becomes effective.
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [ ]
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [ ] ____________
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ] _______________
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
CALCULATION OF REGISTRATION FEE
==============================================================================================================================
Title of Securities to be Amount to be Proposed Maximum Proposed Maximum Amount of
Registered Registered Offering Price Per Share (1) Aggregate Offering Price (1) Registration Fee
------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value
$.01 per share 134,797 $ 15.94 $ 2,148,664.18 $ 173.82
==============================================================================================================================
(1) Estimated pursuant to Rule 457(c) solely for the purpose of calculating
the amount of the registration fee based on the average of the high and
low prices of the Company's Common Stock as reported on the Nasdaq
National Market System on July 8, 2003.
The Registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the Registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933, as amended, or until this Registration Statement
shall become effective on such date as the Commission, acting pursuant to
Section 8(a), may determine.
================================================================================
The information in this prospectus is not complete and may be changed. The
selling stockholders may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This
prospectus is not an offer to sell these securities and it is not soliciting
offers to buy these securities in any state where the offer or sale is not
permitted.
SUBJECT TO COMPLETION, DATED JULY 10, 2003
PROSPECTUS
THE HAIN CELESTIAL GROUP, INC.
134,797 Shares of Common Stock
This prospectus relates to the offer and sale of an aggregate of 134,797
shares of the common stock of The Hain Celestial Group, Inc. by the selling
stockholders listed under the heading "Selling Stockholders." We issued these
shares in connection with our acquisition of Acirca, Inc., which we completed on
June 17, 2003.
Our common stock is traded on the Nasdaq National Market under the symbol
HAIN. The last reported sales price of our common stock as reported by the
Nasdaq National Market System on July 9, 2003 was $16.10 per share.
___________________________
See "Risk Factors" beginning on page 1 for a discussion of certain factors
which should be considered in an investment of securities offered hereby.
___________________________
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS
THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS
PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY
IS A CRIMINAL OFFENSE.
___________________________
The date of this prospectus is __________, 2003.
___________________________
TABLE OF CONTENTS
Page
RISK FACTORS.................................................................1
USE OF PROCEEDS..............................................................8
SELLING STOCKHOLDERS.........................................................9
PLAN OF DISTRIBUTION........................................................10
DESCRIPTION OF CAPITAL STOCK................................................11
LEGAL MATTERS...............................................................12
EXPERTS.....................................................................12
WHERE YOU CAN FIND MORE INFORMATION.........................................13
___________________________
You should rely only on the information contained or incorporated by
reference in this prospectus or to which we have referred you. We have not
authorized anyone to provide you with information that is different. This
prospectus may be used only where it is legal to sell these securities. The
information contained or incorporated by reference in this prospectus may be
accurate only on the date of this prospectus.
This prospectus contains certain forward-looking statements regarding our
future financial condition and results of operations and our business
operations. These statements involve known and unknown risks, uncertainties and
other factors which may cause our actual results, levels of activity,
performance or achievements, or industry results, to be materially different
from any future results, levels of activity, performance or achievements
expressed or implied by such forward-looking statements. These factors include,
among others, the following: general economic and business conditions; our
ability to implement our business and acquisition strategy; our ability to
effectively integrate our acquisitions; our ability to obtain financing for
general corporate purposes; competition; availability of key personnel; and
changes in, or the failure to comply with government regulations; the other
factors discussed in this prospectus (including under the caption "Risk
Factors") and in our other filings with the Securities and Exchange Commission.
If one or more of these risks or uncertainties materialize, or if the underlying
assumptions prove incorrect, actual outcomes may vary materially from those
indicated. The words "expect," "estimate," "anticipate," "predict" and similar
expressions are intended to identify forward-looking statements.
Our principal executive offices are located at 58 South Service Road,
Melville, New York 11747, and our telephone number is 631-730-2200. Our World
Wide Web site address is www.hain-celestial.com. The information on our website
is not part of this prospectus.
References in this prospectus to "we," "us," "our," the "company" and
"Hain" refer to The Hain Celestial Group, Inc. and its subsidiaries.
-ii-
RISK FACTORS
Prospective investors should carefully consider the following factors and
the other information contained in this prospectus before purchasing any shares
of our common stock.
Our Acquisition Strategy Exposes The Company To Risk
We intend to continue to grow our business in part through the acquisition
of new brands and businesses, both in the United States and internationally. Our
acquisition strategy is based on identifying and acquiring businesses with
products and/or brands that complement our existing product mix. We cannot be
certain that we will be able to:
o successfully identify suitable acquisition candidates;
o negotiate identified acquisitions on terms acceptable to us; or
o obtain the necessary financing to complete such acquisitions.
We may encounter increased competition for acquisitions in the future,
which could result in acquisition prices we do not consider acceptable. We are
unable to predict whether or when any prospective acquisition candidate will
become available or the likelihood that any acquisition will be completed.
Our Future Success May Be Dependent On Our Ability To Integrate Companies That
We Acquire
Our future success may be dependent upon our ability to effectively
integrate new brands and businesses that we acquire, including our ability to
realize potentially available marketing opportunities and cost savings, some of
which may involve operational changes. We cannot be certain:
o as to the timing or number of marketing opportunities or amount of
cost savings that may be realized as the result of our integration of
an acquired brand or business;
o that a business combination will enhance our competitive position and
business prospects;
o that we will not experience difficulties with customers, personnel or
other parties as a result of a business combination; or
o that, with respect to our acquisitions outside the United States, we
will not be affected by, among other things, exchange rate risk.
In addition, we cannot be certain that we will be successful in:
o integrating an acquired brand or business's distribution channels with
those of Hain;
o coordinating sales force activities of an acquired company or in
selling the products of an acquired company to our customer base; or
o integrating an acquired company into our management information
systems or in integrating an acquired company's products into our
product mix.
Additionally, integrating an acquired company into Hain's existing
operations will require management resources and may divert our management from
our day-to-day operations. If we are not successful in integrating the
operations of acquired companies, our business could be harmed.
Consumer Preferences For Natural And Organic Or Specialty Food Products And Teas
Are Difficult To Predict And May Change
A significant shift in consumer demand away from our products or our
failure to maintain our current market position could reduce our sales or the
prestige of our brands in our markets, which could harm our business. While we
continue to diversify our product offerings, we cannot be certain that demand
for our products will continue at current levels or increase in the future.
Our business is limited to natural and organic and specialty food products
in markets geared to consumers of natural foods, specialty teas, non-dairy
beverages, cereals, breakfast bars, canned soups and vegetables, snacks and
cooking oils, which, if consumer demand for such categories were to decrease,
could harm our business. Consumer trends change based on a number of possible
factors, including:
o nutritional values, such as a change in preference from fat free to
reduced fat to no reduction in fat; and
o a shift in preference from organic to non-organic and from natural
products to non-natural products.
In addition, we have other product categories, such as medically-directed
food products, kosher foods and other specialty food items. We are subject to
evolving consumer preferences for these products.
Our Markets Are Highly Competitive
We operate in highly competitive geographic and product markets, and some
of our markets are dominated by competitors with greater resources. We cannot be
certain that we could successfully compete for sales to distributors or stores
that purchase from larger, more established companies that have greater
financial, managerial, sales and technical resources. In addition, we compete
for limited retailer shelf space for our products. Larger competitors, such as
mainstream food companies including General Mills, Nestle S.A., Kraft Foods,
Groupe Danone, Kellogg Company and Sara Lee Corporation, also may be able to
benefit from economies of scale, pricing advantages or the introduction of new
products that compete with our products. Retailers also market competitive
products under their own private labels.
The beverage market is large and highly competitive. The tea portion of the
beverage market is also highly competitive. Competitive factors in the tea
industry include product quality and taste, brand awareness among consumers,
variety of specialty tea flavors, interesting or unique product names, product
packaging and package design, supermarket and grocery store shelf space,
alternative distribution channels, reputation, price, advertising and promotion.
We currently compete in the specialty tea market, which consists of herb tea,
green tea, wellness tea and specialty black tea. Our specialty herb tea
products, like other specialty tea products, are priced higher than most
commodity black tea products. Our principal competitors on a national basis in
the specialty tea market are Thomas J. Lipton Company, a division of Unilever
PLC, and R.C. Bigelow, Inc. Unilever has substantially greater financial
resources than our tea business. Additional competitors include a number of
regional specialty tea companies. There may be potential entrants which are not
currently in the specialty tea market who may have
-2-
substantially greater resources than we have. Private label competition in the
specialty tea category is currently minimal.
The soy beverage market, including both aseptic and refrigerated products,
has shown sustained growth over the past several years. A statement by the Food
and Drug Administration endorsing the heart healthy benefits of soy in October
1999 spurred the growth in both the aseptic and refrigerated segments. Aseptic
soy milk is the more mature product category of the two and in the past
twenty-four months, additional larger competitors entered the category but have
since exited the category after unsuccessful regional launches. Westsoy has
taken advantage of the shelf space which became available and continues to be
the number one brand of aseptic soymilk in the grocery and natural channels.
In addition, the refrigerated soy beverage market is primarily driven by
one brand, Silk, which is owned by Dean Foods and holds a significant share of
refrigerated soy milk space through its strong national distribution system. We
have switched our primary focus from refrigerated Westsoy product and redirected
it to focus our efforts on our recently acquired Soy Dream(R) and Rice Dream(R)
refrigerated products, specifically targeting accounts that agree to partner
with us in strong soy milk markets that distribute both aseptic and refrigerated
products.
In the future, our competitors may introduce other products that compete
with our products and these competitive products may have an adverse effect on
our business, results of operations and financial condition.
We Are Dependent Upon The Services Of Our Chief Executive Officer
We are highly dependent upon the services of Irwin D. Simon, our chairman
of the board, president and chief executive officer. We believe Mr. Simon's
reputation as our founder and his expertise and knowledge in the natural and
specialty foods market are critical factors in our continuing growth. The loss
of the services of Mr. Simon could harm our business.
We Rely On Independent Brokers And Distributors For A Substantial Portion Of Our
Sales
We rely upon sales efforts made by or through non-affiliated food brokers
to distributors and other customers. The loss of, or business disruption at, one
or more of these distributors or brokers may harm our business. If we were
required to obtain additional or alternative distribution and food brokerage
agreements or arrangements in the future, we cannot be certain that we will be
able to do so on satisfactory terms or in a timely manner. Two of our
distributors, United Natural Foods and Tree of Life, accounted for approximately
17% and 15%, respectively, of our net sales for the fiscal year ended June 30,
2002, and 18% each for the year ended June 30, 2001. Our inability to enter into
satisfactory brokerage agreements may inhibit our ability to implement our
business plan or to establish markets necessary to develop our products
successfully. Food brokers act as selling agents representing specific brands on
a non-exclusive basis under oral or written agreements generally terminable at
any time on 30 days' notice, and receive a percentage of net sales as
compensation. Distributors purchase directly for their own account for resale.
In addition, the success of our business depends, in large part, upon the
establishment and maintenance of a strong distribution network.
Manufacturing Facilities
We own, manage and operate four manufacturing facilities located throughout
the United States. These facilities are located and produce the following
product lines: Celestial Seasonings(R), in Boulder, Colorado, produces specialty
teas; Terra Chips(R), in Moonachie, New Jersey, produces vegetable chips;
-3-
Arrowhead Mills(R), in Hereford, Texas, produces hot and cold cereals, baking
goods and meal cups; and Deboles(R) pasta, in Shreveport, Louisiana, produces
organic pasta. Outside the United States, we have one manufacturing facility in
Vancouver, Canada (that we acquired in June 2001 in connection with our
acquisition of Yves Veggie Cuisine, Inc.) that produces soy-based meat
substitute products and three manufacturing facilities in Belgium (two that we
acquired in December 2001 in connection with our acquisition of Lima SA and one
that we acquired in May 2003 in connection with our acquisition of Grains Noirs
NV) used for production and warehousing. For the years ended June 30, 2002, 2001
and 2000, approximately 54%, 51% and 55%, respectively, of our revenue was
derived from products manufactured at our manufacturing facilities.
An interruption in or the loss of operations at one or more of these
facilities, or the failure to maintain our labor force at one or more of these
facilities, could delay or postpone production of our products, which could have
a material adverse effect on our business, results of operations and financial
condition until we could secure an alternate source of supply.
We Rely On Independent Co-Packers To Produce Some Or Most Of Our Products
Currently, independent food manufacturers, who are referred to in our
industry as co-packers, manufacture many of our product lines. These product
lines include our Alba(R), Estee(R), Garden of Eatin'(R), Hain Pure Foods(R),
Kineret(R), Little Bear Organic Foods(R), Terra Chips(R), Westbrae(R),
Westsoy(R), Lima(R), Health Valley(R), Casbah(R), Breadshop's(R), Nile Spice(R),
and Imagine(R) product lines. For the fiscal years ended June 30, 2002, 2001 and
2000, products manufactured for us by co-packers represented approximately 46%,
49% and 45%, respectively, of our sales. With the recent acquisitions of Imagine
Foods and Acirca, all of whose products are manufactured by co-packers, and the
recent sale of our Health Valley manufacturing facility to a co-packer, we
anticipate that co-packers will produce a significantly higher proportion of our
products in the future.
In the United States, we presently obtain:
o all of our requirements for non-dairy beverages from five co-packers,
all of which are under contract or other written arrangements;
o all of our requirements for rice cakes from one co-packer;
o all of our Health Valley baked goods and cereal products from one
co-packer, which is under contract;
o all of our cooking oils from one co-packer, which is under contract;
o principally all of our Earth's Best baby food products from one
co-packer, which is under contract;
o principally all of our tortilla chips from three suppliers, one of
which is under contract;
o a portion of our requirements for Terra's Yukon Gold line from one
supplier, which is under contract; and
o the requirements for our canned soups from two suppliers, both of
which are under contract.
-4-
The loss of one or more co-packers, or our failure to retain co-packers for
newly acquired products or brands, could delay or postpone production of our
products, which could harm our business until such time as an alternate source
could be secured, which may be on less favorable terms.
Our Tea Ingredients Are Subject To Import Risk
Our tea business purchases its ingredients from numerous foreign and
domestic manufacturers, importers and growers, with the majority of those
purchases occurring outside of the United States. We maintain long-term
relationships with most of our suppliers. Purchase arrangements with ingredient
suppliers are generally made annually and in U.S. currency. Purchases are made
through purchase orders or contracts, and price, delivery terms and product
specifications vary.
Our botanical purchasers visit major suppliers around the world annually to
procure ingredients and to assure quality by observing production methods and
providing product specifications. Many ingredients are presently grown in
countries where labor-intensive cultivation is possible, and where we often must
educate the growers about product standards. We perform laboratory analysis on
incoming ingredient shipments for the purpose of assuring that they meet our
quality standards and those of the U.S. Food and Drug Administration and the
California Organic Foods Act of 1990.
Our ability to ensure a continuing supply of ingredients at competitive
prices depends on many factors beyond our control, such as foreign political
situations, embargoes, changes in international and world economic conditions,
currency fluctuations forecasting adequate need of seasonal raw material
ingredients and unfavorable climatic conditions. We take steps and will continue
to take steps intended to lessen the risk of an interruption of botanical
supplies, including identification of alternative sources and maintenance of
appropriate inventory levels. We have, in the past, maintained sufficient
supplies for our ongoing operations.
Our failure to maintain relationships with our existing suppliers or find
new suppliers, observe production standards for our foreign procured products or
continue our supply of botanicals from foreign sources could harm our business.
Our Inability To Use Our Trademarks Could Have A Material Adverse Effect On Our
Business
Our inability to use our trademarks could have a material adverse effect on
our business, results of operations and financial condition.
Our trademarks and brand names are registered in the United States and a
number of foreign countries and we intend to keep these filings current and seek
protection for new trademarks to the extent consistent with business needs. We
also copyright certain of our artwork and package designs. We own the trademarks
for our principal products, including Arrowhead Mills(R), Bearitos(R),
Breadshop's(R), Casbah(R), Celestial Seasonings(R), DeBoles(R), Earth's Best(R),
Estee(R), Garden of Eatin'(R), Hain Pure Foods(R), Health Valley(R), Kineret(R),
Little Bear Organic Foods(R), Nile Spice(R), Terra Chips(R), Westbrae(R),
Westsoy(R), Lima(R), Yves(R), Imagine(R), Soy Dream(R), Rice Dream(R), Power
Dream(R) and Imagine Natural(R). We have trademarks for most of the best-selling
Celestial brands, including Sleepytime(R), Lemon Zinger(R), Mandarin Orange
Spice(R), Red Zinger(R), Wild Berry Zinger(R), Tension Tamer(R), Country Peach
Passion(R), Raspberry Zinger(R) and Ginkgo Sharp(R).
We believe that brand awareness is a significant component in a consumer's
decision to purchase one product over another in the highly competitive food and
beverage industry. Our failure to continue to sell our products under our
established brand names could have a material adverse effect on our business,
-5-
results of operations and financial condition. We believe that our trademarks
and trade names are significant to the marketing and sale of our products and
that the inability to utilize certain of these names could have a material
adverse effect on our business, results of operations and financial condition.
Our Products Must Comply With Government Regulation
We and our manufacturers, brokers, distributors and co-packers are subject
to extensive regulation by federal, state and local authorities that affect our
business. The federal agencies governing our business include the Federal Trade
Commission (FTC), The Food and Drug Administration (FDA), the United States
Department of Agriculture (USDA) and the Occupational Safety and Health
Administration (OSHA). These agencies regulate, among other things, the
production, sale, safety, advertising, labeling of and ingredients used in our
products. Under various statutes, these agencies prescribe the requirements and
establish the standards for quality, purity and labeling. Among other
requirements, the USDA must approve our products, including a review of the
manufacturing processes and facilities used to produce these products, as well
as the labeling of these products, before these products can be marketed in the
United States. In addition, advertising of our business is subject to regulation
by the FTC. Our activities are also regulated by state agencies as well as
county and municipal authorities. We are also subject to the laws of the foreign
jurisdictions in which we manufacture and sell our products.
The USDA has adopted regulations with respect to a national organic
labeling and certification program which became effective February 20, 2001, and
fully implemented on October 21, 2002. We currently manufacture approximately
650 organic products which are covered by these new regulations. Future
developments in the regulation of labeling of organic foods could require us to
further modify the labeling of our products, which could affect the sales of our
products and thus harm our business.
In addition, on January 18, 2001, the FDA proposed new policy guidelines
regarding the labeling of genetically engineered foods. The FDA is currently
considering the comments it received before issuing final guidance. These
guidelines, if adopted, could require us to modify the labeling of our products,
which could affect the sales of our products and thus harm our business.
Furthermore, new government laws and regulations may be introduced in the
future that could result in additional compliance costs, seizures,
confiscations, recalls or monetary fines, any of which could prevent or inhibit
the development, distribution and sale of our products. If we fail to comply
with applicable laws and regulations, we may be subject to civil remedies,
including fines, injunctions, recalls or seizures, as well as potential criminal
sanctions, which could have a material adverse effect on our business, results
of operations and financial condition.
In addition, through our Celestial Seasonings subsidiary, we previously
manufactured and sold dietary supplements which are subject to the Dietary
Supplement Health and Education Act of 1994, or DSHEA, which went into effect in
March 1999. DSHEA defines dietary supplements as a new category of food,
separate from conventional food. DSHEA requires specific nutritional labeling
requirements for dietary supplements and permits substantiated, truthful and
non-misleading statements of nutritional support to be made in labeling, such as
statements describing general well-being resulting from consumption of a dietary
ingredient, or the role of a nutrient or dietary ingredient in affecting or
maintaining a structure or function of the body.
-6-
Product Recalls Could Have A Material Adverse Effect On Our Business
Manufacturers and distributors of products in the food industry are
sometimes subject to the recall of their products for a variety of reasons,
including for product defects, such as ingredient contamination, packaging
safety and inadequate labeling disclosure. If any of our products are recalled
due to a product defect or for any other reason, we could be required to incur
the expense of the recall or the expense of any resulting legal proceeding.
Additionally, if one of our significant brands were subject to recall, the image
of that brand and our company could be harmed, which could have a material
adverse effect on our business.
Product Liability Suits, If Brought, Could Have A Material Adverse Effect On Our
Business
If a product liability claim exceeding our insurance coverage were to be
successfully asserted against us, it could harm our business. We cannot assure
you that such coverage will be sufficient to insure against claims which may be
brought against us, or that we will be able to maintain such insurance or obtain
additional insurance covering existing or new products. As a marketer of food
products, we are subject to the risk of claims for product liability. We
maintain product liability insurance and generally require that our co-packers
maintain product liability insurance with us as a co-insured.
We Rely On Independent Certification For A Number Of Our Natural And Specialty
Food Products
We rely on independent certification, such as certifications of our
products as "organic" or "kosher," to differentiate our products in natural and
specialty food categories. The loss of any independent certifications could
adversely affect our market position as a natural and specialty food company,
which could harm our business.
We must comply with the requirements of independent organizations or
certification authorities in order to label our products as certified. For
example, we can lose our "organic" certification if a plant becomes contaminated
with non-organic materials, or if not properly cleaned after a production run.
In addition, all raw materials must be certified organic. Similarly, we can lose
our "kosher" certification if a plant and raw materials do not meet the
requirements of the appropriate kosher supervision organization, such as The
Union of Orthodox Jewish Congregations, The Organized Kashruth Laboratories,
"KOF-K" Kosher Supervision, Kosher Overseers Associated of America and Upper
Midwest Kashruth.
Due To The Seasonality Of Many Of Our Products, Including Our Tea Products, And
Other Factors, Our Operating Results Are Subject To Quarterly Fluctuations
Our tea business consists primarily of manufacturing and marketing hot tea
products and as a result its quarterly results of operations reflect seasonal
trends resulting from increased demand for its hot tea products in the cooler
months of the year. In addition, some of our other products (e.g., baking and
cereal products and soups) also show stronger sales in the cooler months while
our snack food product lines are stronger in the warmer months. Quarterly
fluctuations in our sales volume and operating results are due to a number of
factors relating to our business, including the timing of trade promotions,
advertising and consumer promotions and other factors, such as seasonality,
inclement weather and unanticipated increases in labor, commodity, energy,
insurance or other operating costs. The impact on sales volume and operating
results due to the timing and extent of these factors can significantly impact
our business. For these reasons, you should not rely on our quarterly operating
results as indications of future performance. In some future periods, our
operating results may fall below the expectations of securities analysts and
investors, which could harm our business.
-7-
Our Officers And Directors May Be Able To Control Our Actions
Our officers and directors beneficially own approximately 10.8% of our
common stock as of May 6, 2003. In addition, two of these directors currently
serve as a designee and a jointly appointed designee of an affiliate of H.J.
Heinz Company, or Heinz, which owns approximately 17.9% of our common stock as
of May 6, 2003. Accordingly, our officers and directors may be in a position to
influence the election of our directors and otherwise influence stockholder
action.
Our Ability To Issue Preferred Stock May Deter Takeover Attempts
Our board of directors is empowered to issue, without stockholder approval,
preferred stock with dividends, liquidation, conversion, voting or other rights
which could decrease the amount of earnings and assets available for
distribution to holders of our common stock and adversely affect the relative
voting power or other rights of the holders of our common stock. In the event of
issuance, the preferred stock could be used as a method of discouraging,
delaying or preventing a change in control. Our certificate of incorporation
authorizes the issuance of up to 5,000,000 shares of "blank check" preferred
stock with such designations, rights and preferences as may be determined from
time to time by our board of directors. Although we have no present intention to
issue any shares of our preferred stock, we may do so in the future under
appropriate circumstances.
USE OF PROCEEDS
We will not receive any of the proceeds from the sale of shares by the
selling stockholders. All of the proceeds from the sale of shares of common
stock by the selling stockholders will be received by the selling stockholders.
-8-
SELLING STOCKHOLDERS
The following table shows information regarding ownership of the shares of
common stock held by the selling stockholders. We issued the shares of our
common stock being registered in connection with our acquisition of Acirca,
Inc., which we completed on June 17, 2003.
Number of
Shares of
Common Stock Number of Shares of
Beneficially Common Stock
Name Owned Percent of Class Registered Hereby
-------------------------------------- ------------------- ---------------- -------------------
ZG Ventures, L.L.C. * 22,423
CG Organics, L.L.C. * 21,843
Pan Pacific Ventures, L.P. * 22,426
Catalyst II * 427
Florida Avenue Partnership * 1,362
Kulea LLC * 37,222
Turner Organics, LLC * 26,313
Kenneth J. Novack * 1,041
Ross Revocable Trust u/a dated * 1,100
January 31, 1996
Mark S. Rodriguez * 341
Mark Koide * 171
Olivier Sonnois * 128
________________
* Represents less than 1% of our outstanding common stock.
Each selling stockholder has represented to us that the shares of common
stock listed opposite such selling stockholder's name under the heading "Number
of Shares of Common Stock Registered Hereby" were acquired for such selling
stockholder's own account, not as nominee or agent, and not with a view to, or
for resale in connection with, any distribution thereof. In recognition of the
fact that the selling stockholders may wish to be legally permitted to sell the
shares in the future, we agreed with the selling stockholders to file with the
Commission under the Securities Act the registration statement with respect to
the sale of the shares from time to time in transactions on the Nasdaq National
Market (or other market or exchange on which our common stock is traded), in
privately negotiated transactions, or through a combination of these methods of
sale, and have agreed to prepare and file such amendments and supplements to the
registration statement as may be necessary to keep the registration statement
effective until the shares are no longer required to be registered for the sale
thereof by the selling stockholders.
-9-
PLAN OF DISTRIBUTION
All of the shares offered hereby may be sold from time to time by the
selling stockholders or by his, her or its registered assigns. The shares
offered hereby may be sold by one or more of the following methods: (a) a block
trade in which a broker or dealer so engaged will attempt to sell the shares as
agent but may purchase and resell a portion of the block as principal to
facilitate the transaction; (b) purchases by a broker or dealer as principal and
resale by such broker or dealer for its account pursuant to this prospectus; (c)
ordinary brokerage transactions and transactions in which the broker solicits
purchasers; (d) privately negotiated transactions; and (e) face-to-face
transactions between sellers and purchasers without a broker-dealer.
The selling stockholders may be deemed to be statutory underwriters under
the Securities Act. Also any broker-dealers who act in connection with the sale
of the shares hereunder may be deemed to be "underwriters" within the meaning of
Section 2(11) of the Securities Act, and any commissions received by them and
profit on any resale of the shares as principal may be deemed to be underwriting
discounts and commissions under the Securities Act.
In effecting sales, brokers or dealers engaged by the selling stockholders
may arrange for other brokers or dealers to participate. Such brokers or dealers
may receive commissions or discounts from the selling stockholders in amounts to
be negotiated by the selling stockholders. The selling stockholders may enter
into hedging transactions with broker-dealers and the broker-dealers may engage
in short sales of the common stock in the course of hedging the positions they
assume with the selling stockholders (including in connection with the
distribution of the common stock by such broker-dealers). The selling
stockholders may also engage in short sales of the common stock and may enter
into option or other transactions with broker-dealers that involve the delivery
of the common stock to the broker-dealers, who may then resell or otherwise
transfer such common stock. Such broker-dealers and any other participating
broker-dealers may, in connection with such sales, be deemed to be underwriters
within the meaning of the Securities Act. Any discounts or commissions received
by any such broker-dealers may be deemed to be underwriting discounts and
commissions under the Securities Act.
The selling stockholders may also sell shares in accordance with Rule 144
under the Securities Act, if Rule 144 is then available.
In order to comply with the securities laws of certain states, if
applicable, the shares will be sold in such jurisdictions only through
registered or licensed broker-dealers.
We will pay all of the expenses incident to the filing of this registration
statement, estimated to be $27,000. These expenses include legal and accounting
fees in connection with the preparation of the registration statement of which
this prospectus is a part, legal and other fees in connection with the
qualification of the sale of the shares under the laws of certain states (if
any), registration and filing fees and other expenses. The selling stockholders
will pay all other expenses incident to the offering and sale of the shares to
the public, including commissions and discounts of underwriters, brokers,
dealers or agents, if any. We have agreed to keep the registration of the shares
offered hereby effective until the earlier of the date when all of the shares
offered by the selling stockholders have been sold or two years from the date
the shares were issued.
-10-
DESCRIPTION OF CAPITAL STOCK
General
Our authorized capital stock consists of 100,000,000 shares of common
stock, $.01 par value per share, and 5,000,000 shares of preferred stock, $.01
par value per share.
The following description is qualified in all respects by reference to our
certificate of incorporation and the bylaws.
Common Stock
Each share of common stock entitles the holder thereof to one vote on all
matters submitted to a vote of the stockholders. Since the holders of common
stock do not have cumulative voting rights, holders of more than 50% of the
outstanding shares can elect all of our directors then being elected and holders
of the remaining shares by themselves cannot elect any directors. The holders of
common stock do not have preemptive rights or rights to convert their common
stock into other securities. Holders of common stock are entitled to receive
ratably such dividends as may be declared by our board of directors out of funds
legally available therefor. In the event of our liquidation, dissolution or
winding up, holders of the common stock have the right to a ratable portion of
the assets remaining after payment of liabilities. All outstanding shares of
common stock are fully paid and nonassessable.
Preferred Stock
We are authorized by our certificate of incorporation to issue a maximum of
5,000,000 shares of preferred stock, in one or more series and containing such
rights, privileges and limitations including voting rights, dividend rates,
conversion privileges, redemption rights and terms, redemption prices and
liquidation preferences, as our board of directors may, from time to time,
determine.
The issuance of shares of preferred stock pursuant to our board of
directors' authority described above could decrease the amount of earnings and
assets available for distribution to holders of common stock, and otherwise
adversely affect the rights and powers, including voting rights, of such holders
and may have the effect of delaying or preventing us from being subject to a
change in control. See "Risk Factors -- Our Ability To Issue Preferred Stock May
Deter Takeover Attempts." We are not required by the Delaware General
Corporation Law, or the DGCL, to seek stockholder approval prior to any issuance
of authorized but unissued stock and our board of directors does not currently
intend to seek stockholder approval prior to any issuance of authorized but
unissued stock, unless otherwise required by law.
Certificate of Incorporation and Bylaws
Pursuant to the DGCL, the power to adopt, amend and repeal bylaws is
conferred solely upon the stockholders unless the corporation's certificate of
incorporation also confers such power upon the board of directors. Under our
certificate of incorporation, our board of directors is granted the power to
amend our bylaws. Our bylaws provide that each director has one vote on each
matter for which directors are entitled to vote. Our certificate of
incorporation and/or bylaws also provide that (1) from time to time, by
resolution, our board of directors has the power to change the number of
directors, (2) the directors will hold office until the next annual meeting of
stockholders and until their respective successors are elected and qualified,
and (3) special meetings of stockholders may only be called by our board of
directors or our officers. These provisions, in addition to the existence of
authorized but unissued capital stock, may have the effect, either alone or in
combination with each other, of making more difficult or discouraging
-11-
unsolicited third parties from an acquisition of us deemed undesirable by our
board of directors. Our board of directors currently has eleven members.
Section 203 of the Delaware Law
Section 203 of the DGCL prohibits a publicly held Delaware corporation from
engaging in a "business combination" with an "interested stockholder" for a
period of three years after the date of the transaction in which the person
became an interested stockholder, unless (1) prior to the date of the business
combination, the transaction is approved by the board of directors of the
corporation; (2) upon consummation of the transaction which resulted in the
stockholder becoming an interested stockholder, the interested stockholder owns
at least 85% of the outstanding voting stock, or (3) on or after such date the
business combination is approved by the board of directors and by the
affirmative vote of at least 66-2/3% of the outstanding voting stock that is not
owned by the interested stockholder. A "business combination" includes mergers,
asset sales and other transactions resulting in a financial benefit to the
stockholder. An "interested stockholder" is a person, who, together with
affiliates and associates, owns (or within three years, did own) 15% or more of
the corporation's voting stock. This provision of law could discourage, prevent
or delay a change in management or stockholder control of us, which could have
the effect of discouraging bids and thereby prevent stockholders from receiving
the maximum value for their shares, or a premium for their shares in a hostile
takeover situation.
Transfer Agent and Registrar
The Transfer Agent and Registrar for the common stock is Continental Stock
Transfer & Trust Company, New York, New York.
LEGAL MATTERS
Certain legal matters with respect to the validity of the common stock
offered hereby will be passed upon for us by Cahill Gordon & Reindel LLP, New
York, New York. From time to time, Cahill Gordon & Reindel LLP has represented
us and may continue to represent us and our subsidiaries in connection with
various legal matters. Roger Meltzer, a partner of Cahill Gordon & Reindel LLP,
is also a member of our board of directors. Mr. Meltzer receives compensation as
a board member.
EXPERTS
The consolidated financial statements of The Hain Celestial Group, Inc. and
Subsidiaries appearing in The Hain Celestial Group, Inc.'s Annual Report (Form
10-K) for the year ended June 30, 2002, have been audited by Ernst & Young LLP,
independent auditors, as set forth in their report thereon included therein and
incorporated herein by reference. Such consolidated financial statements are
incorporated herein by reference in reliance upon such report given on the
authority of such firm as experts in accounting and auditing.
-12-
WHERE YOU CAN FIND MORE INFORMATION
We file annual, quarterly and special reports, proxy statements and other
information with the Commission. You can receive copies of such reports, proxy
and information statements, and other information, at prescribed rates, from the
Commission by addressing written requests to the Public Reference Section of the
Commission at 450 Fifth Street, N.W., Judiciary Plaza, Washington, D.C. 20549.
You may also read and copy any document we file with the SEC at its public
reference facilities at 450 Fifth Street, N.W., Washington, D.C. 20549. Please
call the Commission at 1-800-SEC-0330 for further information on the public
reference rooms. The Commission also maintains a web site that contains reports,
proxy and information statements and other information regarding registrants
such as us, that file electronically with the Commission. The address of the
Commission's web site is http://www.sec.gov.
This prospectus is part of a registration statement on Form S-3 that we
filed with the Commission to register the shares that the selling stockholders
will sell in this offering. This prospectus does not include all of the
information contained in the registration statement. For further information
about us and the securities offered in this prospectus, you should review the
registration statement and the information incorporated by reference therein.
You can inspect or copy the registration statement, at prescribed rates, at the
Commission's public reference facilities at the address listed above.
The Commission allows us to "incorporate by reference" information into the
prospectus, which means that we can disclose important information to you by
referring you to those documents filed separately with the Commission. The
information incorporated by reference is considered part of this prospectus, and
information that we file later with the Commission will automatically update and
supersede this information.
This prospectus incorporates by reference the documents listed below that
we previously filed with the Commission. These documents contain important
information about us and our finances:
HAIN'S SEC FILINGS
(FILE NO. 0-22818) PERIOD
------------------------------------- ----------------------------------------
Annual Report on Form 10-K Fiscal year ended June 30, 2002
Quarterly Reports on Form 10-Q Quarters ended September 30, 2002,
December 31, 2002 and March 31, 2003
Current Reports on Form 8-K Filed on September 4, 2002,
December 3, 2002 and July 1, 2003
We also incorporate by reference additional documents that we may file with
the Commission after the initial filing date of the registration statement of
which this prospectus is a part and before the completion of the resale by the
selling stockholders. These additional documents include periodic reports, such
as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current
Reports on Form 8-K, as well as proxy statements. Upon request, we will provide
without charge to each person to whom a prospectus is delivered, including any
beneficial owner, a copy of any or all of the information that has been
incorporated by reference in this prospectus. If you would like to obtain this
information from us, please direct your request, either in writing or by
telephone, to the President, The Hain Celestial Group, Inc., 58 South Service
Road, Melville, New York, 11747, (631) 730-2200.
-13-
================================================================================
The Hain Celestial Group, Inc.
Common Stock
_______________
PROSPECTUS
________________
, 2003
================================================================================
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
The following table sets forth the costs and expenses, other than discounts
and commissions, if any, incurred in connection with the sale of common stock
being registered (all amounts are estimated except the Securities and Exchange
Commission registration fee and the Nasdaq National Market Listing fee). We will
bear all expenses incurred in connection with the sale of the common stock being
registered hereby, and the selling stockholders will not bear any portion of
such expenses, other than commissions and discounts relating to the shares to be
sold by the selling stockholders, if any.
Securities and Exchange Commission Registration Fee.......... $ 174
Nasdaq National Market Listing Fee........................... 1,348
Legal Fees and Expenses...................................... 20,000
Accounting Fees and Expenses................................. 5,000
Miscellaneous................................................ 478
---------
Total............................................... $ 27,000
=========
Item 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
1. Indemnification. Delaware Law. Section 145 of the Delaware General
Corporation Law, or the DGCL, provides that a corporation may indemnify a
director or officer by a provision contained in the certificate of incorporation
or by-laws or by a duly authorized resolution of its stockholders or directors
or by agreement, provided that no indemnification may be made to or on behalf of
any director or officer if a judgment or other final adjudication adverse to the
director or officer establishes that his acts were committed in bad faith or
were the result of active and deliberate dishonesty and material to the cause of
action, or that such director or officer personally gained in fact a financial
profit or other advantage to which he was not legally entitled.
Section 145(a) of the DGCL provides that a corporation may indemnify a
director or officer made, or threatened to be made, a party to any threatened,
pending or completed action other than a derivative action, whether civil or
criminal, against expenses (including attorneys' fees), judgments, fines,
amounts paid in settlement actually and reasonably incurred as a result of such
action, if such director or officer acted, in good faith, for a purpose which he
reasonably believed to be in, or not opposed to, the best interests of the
corporation and, in criminal actions or proceedings, in addition, has no
reasonable cause to believe that his conduct was unlawful.
Section 145(b) of the DGCL provides that a corporation may indemnify a
director or officer, made or threatened to be made a party in a derivative
action, against expenses (including attorneys fees) actually and reasonably
incurred by such person in connection with the defense or settlement of such
action, if such director or officer acted, in good faith, and in a manner such
person reasonably believed to be in, or not opposed to, the best interests of
the corporation, except that no indemnification will be made in respect of any
claim as to which such director or officer shall have been adjudged liable to
the corporation, unless and only to the extent that the Court of Chancery or the
court in which the action was
II-1
brought determines, upon application, that, in view of all the circumstances of
the case, the director or officer is fairly and reasonably entitled to indemnity
for such expenses as the Court of Chancery or such other court deems proper
Section 145(d) of the DGCL specifies the manner in which payment of
indemnification under Section 145(a) of the DGCL or indemnification permitted
under Section 145(b) of the DGCL may be authorized by the corporation. Section
145(c) of the DGCL provides that indemnification by a corporation is mandatory
in any case in which a present or former director or officer has been
successful, whether on the merits or otherwise, in defending an action. In the
event that the director or officer has not been successful or the action is
settled, indemnification must be authorized by the appropriate corporate action
as set forth in Section 145(d).
Section 145(g) of the DGCL authorizes the purchase and maintenance of
insurance to indemnify (1) a corporation for any obligation which it incurs as a
result of the indemnification of directors and officers under the above section
or (2) directors and officers in instances in which they may be indemnified by a
corporation under such section.
2. Hain's Certificate of Incorporation and Bylaws. Article Eleventh of the
Certificate of Incorporation and Article IV of the Bylaws of Hain provides for
Hain to indemnify its corporate personnel, directors and officers to the full
extent permitted by Section 145 of the DGCL, as the same may be supplemented or
amended from time to time.
Item 16. EXHIBITS.
The following exhibits are filed as part of this Registration Statement:
Exhibit No. Description
----------- -----------
5 Opinion of Cahill Gordon & Reindel LLP regarding the legality of the
securities being registered.
23.1 Consent of Ernst & Young LLP, Independent Auditors.
23.2 Consent of Cahill Gordon & Reindel LLP (included in Exhibit 5).
24 Powers of Attorney authorizing execution of Registration Statement on
Form S-3 on behalf of certain directors of Registrant (included on the
signature pages to the Registration Statement).
II-2
Item 17. UNDERTAKINGS.
(A) The undersigned registrant hereby undertakes:
1. To file, during any period in which offers or sales are being made,
a post-effective amendment to this Registration Statement:
(a) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933; unless the information required to be included
in such post-effective amendment is contained in a periodic report
filed by the Company pursuant to Section 13 or Section 15(d) of the
Securities Exchange Act of 1934 and incorporated herein by reference;
(b) To reflect in the prospectus any acts or events arising after
the effective date of the Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth
in the Registration Statement, unless the information required to be
included in such post-effective amendment is contained in a periodic
report filed by the registrant pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934 and incorporated herein by
reference; and
(c) To include any material information with respect to the plan
of distribution not previously disclosed in the Registration Statement
or any material change to such information in the Registration
Statement.
2. That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof.
3. To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.
(B) The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to section 13(a) or section 15(d) of the
Securities Exchange Act of 1934 that is incorporated by reference in the
Registration Statement shall be deemed to be a new Registration Statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
(C) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the Securities and Exchange
Commission, such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such
II-3
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized.
Dated: July 10, 2003 THE HAIN CELESTIAL GROUP, INC.
By: /s/ Ira J. Lamel
--------------------------------------
Name: Ira J. Lamel
Title: Executive Vice President,
Chief Financial Officer and
Treasurer
II-5
Each person whose signature appears below in so signing also makes,
constitutes and appoints Irwin D. Simon and Ira J. Lamel, and each of them
acting alone, his true and lawful attorney-in-fact, with full power of
substitution, for him in any and all amendments and post-effective amendments to
this registration statement, and any registration statement for the same
offering covered by this registration statement that is to be effective upon
filing pursuant to Rule 462(b) under the Securities Act of 1933, and all
post-effective amendments thereto together with exhibits to any such
registration statements or amendments and other documents in connection
therewith, and hereby ratifies and confirms all that said attorney-in-fact or
said attorney-in-fact's substitute or substitutes may do or cause to be done by
virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed on July 10, 2003 by the following
persons in the capacities indicated.
Name Title
---- -----
/s/ Irwin D. Simon Chairman of the Board, President and
----------------------------- Chief Executive Officer
Irwin D. Simon (Principal Executive Officer)
/s/ Ira J. Lamel Executive Vice President, Chief Financial
----------------------------- Officer and Treasurer (Principal Financial
Ira J. Lamel and Accounting Officer)
/s/ Beth L. Bronner Director
-----------------------------
Beth L. Bronner
/s/ Jack Futterman Director
-----------------------------
Jack Futterman
/s/ James S. Gold Director
-----------------------------
James S. Gold
/s/ Marina Hahn Director
-----------------------------
Marina Hahn
/s/ Andrew R. Heyer Director
-----------------------------
Andrew R. Heyer
/s/ Joseph Jimenez Director
-----------------------------
Joseph Jimenez
/s/ Roger Meltzer Director
-----------------------------
Roger Meltzer
Director
-----------------------------
Daniel R. Glickman
II-6
Director
-----------------------------
Michael J. Bertasso
Director
-----------------------------
Larry Zilavy
II-7
INDEX TO EXHIBITS
Exhibit No. Description
----------- -----------
5 Opinion of Cahill Gordon & Reindel LLP regarding the legality of the
securities being registered.
23.1 Consent of Ernst & Young LLP, Independent Auditors.
23.2 Consent of Cahill Gordon & Reindel LLP (included in Exhibit 5).
24 Powers of Attorney authorizing execution of Registration Statement on
Form S-3 on behalf of certain directors of Registrant (included in
signature pages to the Registration Statement).
Exhibit 5
Cahill Gordon & Reindel LLP
80 Pine Street
New York, New York 10005
July 10, 2003
Securities and Exchange Commission
450 5th Street, N.W.
Washington, D.C. 20549
Re: The Hain Celestial Group, Inc.
Registration Statement on Form S-3
----------------------------------
Ladies and Gentlemen:
We have acted as special counsel to The Hain Celestial Group, Inc. (the
"Company") in connection with the preparation of the Company's registration
statement on Form S-3 (the "Registration Statement") filed with the Securities
and Exchange Commission (the "Commission") under the Securities Act of 1933, as
amended (the "Securities Act"), in connection with the sale by the selling
stockholders listed therein of up to 134,797 shares of common stock of the
Company, par value $.01 per share (the "Shares").
In rendering the opinion set forth herein, we have examined originals,
photocopies or conformed copies certified to our satisfaction of all such
corporate records, agreements, instruments and documents of the Company,
certificates of public officials and other certificates and opinions, and we
have made such other investigations, as we have deemed necessary in connection
with the opinions set forth herein. In our examination, we have assumed the
genuineness of all signatures, the authenticity of all documents submitted to us
as originals and the conformity to originals of all documents submitted to us as
photocopies or conformed copies.
Based on the foregoing, and subject to the effectiveness of the
Registration Statement under the Securities Act, we advise you that in our
opinion, the Shares are legally issued, fully paid and nonassessable.
We are members of the bar of the State of New York, and in rendering this
opinion we express no opinion as to the laws of any jurisdiction other than the
laws of the State of New York, the State of Delaware and the Federal laws of the
United States of America.
We hereby consent to the use of our firm's name under the caption "Legal
Matters" and to the filing of a copy of this opinion with the Commission as an
exhibit to the Registration Statement referred to above.
Very truly yours,
/s/ Cahill Gordon & Reindel LLP
Exhibit 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of The Hain Celestial
Group, Inc. for the registration of 134,797 shares of its common stock and to
the incorporation by reference therein of our report dated August 28, 2002, with
respect to the consolidated financial statements and schedule of The Hain
Celestial Group, Inc. included in its Annual Report (Form 10-K) for the year
ended June 30, 2002, filed with the Securities and Exchange Commission.
/s/ ERNST & YOUNG LLP
Melville, New York
July 10, 2003